Sickle Cell Disease Clinical Trials in Oakland, California

5 studies are recruiting for sickle cell disease in Oakland, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

   Etavopivat is a new medicine under development for treating blood disorders like sickle cell disease and thalassaemia. Sickle cell disease and thalassaemia are inherited blood disorders that affect haemoglobin. Haemoglobin is the protein that carries oxygen through the body. This study is looking i…

   Stage

   Phase 3

   Ages

   2 and older

   Site

   UCSF Oakland Benioff ChildHosp, Oakland, California

   Locations

   107 in total

   Run by

   Novo Nordisk A/S

   See if you can join NCT06609226 on ClinicalTrials.gov

2. ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

   In parallel with the growth of ATHN's clinical studies, the number of new therapies for all blood disorders is increasing significantly. Some of the recently FDA-approved therapies for congenital and acquired hematologic conditions have not yet demonstrated long-term safety and effectiveness beyond…

   Stage

   Not phased

   Ages

   Any age

   Site

   UCSF Benioff Children's Hospital Oakland, Oakland, California

   Locations

   76 in total

   Run by

   American Thrombosis and Hemostasis Network

   See if you can join NCT04398628 on ClinicalTrials.gov

3. Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease

   This is an open label, non-randomized, 2-center, phase 1/2 trial of a single infusion of sickle allele modified cluster of differentiation (CD34+) hematopoietic stem progenitor cells (HSPCs) in subjects with in subjects ≥12 years old to 35 years old severe Sickle Cell Disease (SCD). The study will …

   Stage

   Phase 1

   Ages

   12 to 35

   Site

   UCSF Benioff Children's Hospital, Oakland, California

   Locations

   2 in total

   Run by

   Mark Walters, MD

   See if you can join NCT04774536 on ClinicalTrials.gov

4. Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial

   The goal of this short term prospective Phase II study is to compare the effects of two alternate daily doses of zinc (25 and 40 mg/day) in 34 randomly assigned homozygous Sickle Cell Disease (SCD-SS) patients aged 15-40 years old. The main question it aims to answer is: Which biomarkers are most r…

   Stage

   Phase 2

   Ages

   15 to 40

   Site

   UCSF Benioff Children's Hospital Oakland, Oakland, California

   Locations

   6 in total

   Run by

   University of California, San Francisco

   See if you can join NCT06260891 on ClinicalTrials.gov

5. Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

   The goal of this observational study is to help us understand more about the best ways to help individuals living with Sickle Cell Disease (SCD) get the best care. The main question it aims to answer is: How to find individuals unaffiliated from SCD specialist care use three distinct pathways? Once…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of California, San Francisco (UCSF), Oakland, California

   Locations

   9 in total

   Run by

   RTI International

   See if you can join NCT06385886 on ClinicalTrials.gov